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Abstract
Background:  Small-cell neuroendocrine carcinoma in the duodenum is an extremely rare
neoplasm with poor prognosis.
Case presentation: A 57-year-old man presented with sudden onset gastrointestinal bleeding
and fainting attacks. Duodenoscopy and hypotonic duodenography revealed a 3 × 3 cm protruding
tumor with ulcerations situated opposite the ampulla of Vater in the second part of the duodenum.
Local excision of the tumor was performed, followed by adjuvant chemotherapy with 5-fluoro
uracil and leucovorin. Examination of the tumor by immunohistochemistry and electron
microscopy indicated it to be neuroendocrine in nature, expressing synaptophysin and AE1/AE3,
and containing dense core granules. The patient showed no sign of recurrence and has been
disease-free for more than 48 months after surgery.
Conclusions: Most cases of small-cell neuroendocrine carcinoma in the duodenum show rapid
progression of the disease, and even radical surgery with or without chemotherapy do not prevent
death. We report a rare subtype of small-cell neuroendocrine carcinoma. This subtype appears to
have a much better prognosis, and may be amenable to local excision, if the lesion is away from the
ampulla of Vater.
Background
Duodenal Neuroendocrine tumors constitute 5% of all
gastrointestinal neuroendocrine tumors [1,2]. Most of
these show well-differentiated features and are classified
as carcinoids or somatostatinomas [3-6]. Occurrence of
carcinoma is rare, and carcinomas with anaplastic charac-
ter, which are classified as small-cell carcinomas, are even
less frequent [7-12]. The most common small-cell neu-
roendocrine carcinoma (NEC) is the small-cell undiffer-
entiated carcinoma of the lung [13,14]. Although the
features of these pulmonary tumors are well defined, the
characteristics of their extrapulmonary counterparts are
still unknown. We report a case of small-cell NEC in the
duodenum that had unique morphological features and
exceptionally good clinical outcome.
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Case presentation
A 57-year-old man presented with sudden gastrointestinal
tract bleeding and episode of fainting. Duodenoscopy
(Figure 1a) and hypotonic duodenography (Figure 1b)
revealed a 3 × 3 cm protruding tumor with two ulcerations
located opposite the ampulla of Vater in the second part
of the duodenum. Laboratory data showed no abnormal-
ities in blood chemistry, tumor markers (CEA, CA19-9,
NSE, proGRP) and endocrine markers (somatostatin, gas-
trin, glucagons, serotonin, VIP) except a moderate anemia
(9.5 g/dl hemoglobin). No abnormal findings were
observed in the chest X-ray and computed tomography
(CT).
A laparotomy was performed. As there was no serosal
invasion or regional lymphadenopathy wide local exci-
sion of the tumor was performed. On gross examination,
the tumor showed two ulcerations and two different mor-
phological components (Figure 2a and 2b). One compo-
nent (component A) was round in shape with a round
ulceration on the top, and the other component (compo-
nent B), which enclosed the round component, was cres-
cent in shape with a spindle-shaped ulceration on the top.
The two components showed different histopathological
and immunohistochemical features (Table 1). The round
component contained fibrous tissue, small nuclei, and
clear nucleoli. Histopathologically, the crescent compo-
nent had more anaplastic features typical of small-cell car-
cinoma, such as sheets of tightly packed anaplastic cells
with round nuclei and scanty cytoplasm (Figure 2c, 2d).
Neuroendocrine differentiation was investigated using
immunohistochemical and ultrastructural techniques.
Both components showed neuroendocrine features, with
immunochemistry identifying synaptophysin and AE1/
AE3 (Figure 3a and 3b), and electron microscopy identify-
ing dense core granules (Figure 4). Immunochemistry also
showed that the crescent component expressed less cytok-
eratin, vimentin and CD56, and more MIB-1 than the
round component.
The patient was discharged three weeks after operation
with uneventful postoperative period. Four cycles of
monthly adjuvant chemotherapy with 5-fluoro uracil (5-
FU) (325 mg/m2) and leucovorin (20 mg/m2) were
administered. The patient showed no sign of recurrence
and is disease-free 48 months after surgery.
Discussion
Neuroendocrine carcinomas (NEC) in the duodenum are
extremely rare, and are classified as either 'small-cell' or
'non small-cell' types. The small-cell NEC occurring in the
duodenum and elsewhere in gastrointestinal tract are sim-
ilar to the small-cell carcinoma of the lung [7,8]. Only
eight cases of small-cell NEC in the duodenum have been
(a) Duodenoscopy showing a 3 × 3 cm protruding tumor with two ulcerations located opposite the ampulla of Vater in the  second portion of the duodenum Figure 1
(a) Duodenoscopy showing a 3 × 3 cm protruding tumor with two ulcerations located opposite the ampulla of Vater in the 
second portion of the duodenum. (b) Hypotonic duodenography showing the donuts-shape tumor in the duodenum.World Journal of Surgical Oncology 2004, 2:28 http://www.wjso.com/content/2/1/28
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reported, with the present case being the ninth (Table 2)
[7-12]. Most cases occurred in middle-aged or geriatric
males with lesions in the ampulla of Vater. Extra-ampul-
lary small-cell NECs in the duodenum are extremely rare,
with only two cases reported previously [7,8].
The natural course of small-cell NECs in the duodenum is
still not clear. Most cases reported in the literature show
rapid progress of the disease, with radical surgery and/or
chemotherapy not altering the clinical course, and thus a
poor prognosis. In six of the previous eight cases, patients
underwent pancreaticoduodenectomy for removal of the
tumor, while the remaining two did not undergo surgery
Macroscopic and microscopic findings of the tumor Figure 2
Macroscopic and microscopic findings of the tumor. (a) Gross appearance of the tumor. The tumor was divided into two com-
ponents, component A (round shape) and B (crescent shape). (b) Photomicrograph of the gross appearance of the tumor 
(Hematoxylin and eosin X 2). (c) Photomicrograph of the component A showing fibrous tissue, small nuclei, and clear nucleoli. 
(Hematoxylin and Eosin X 40). (d) Photomicrograph of the component B showing more anaplastic features typical of small-cell 
carcinoma, such as sheets of tightly packed anaplastic cells with round nuclei and scanty cytoplasm. (Hematoxylin and Eosin X 
40).World Journal of Surgical Oncology 2004, 2:28 http://www.wjso.com/content/2/1/28
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because of multiple liver metastasis or poor general con-
dition. In spite of radical resection with or without
adjuvant chemotherapy, most cases showed rapid recur-
rence and metastasis. Of the eight reported cases, one was
unusual as it occurred in a middle-aged female with rapid
progress of the disease but effective response to adjuvant
chemotherapy using 5FU, tumor necrosis factor, and
interferon this patient survived for more than eighteen
months [10]. The present case was treated by a local exci-
sion of the tumor followed by adjuvant chemotherapy
using 5-FU and leucovorin, and showed a distinctively
unique clinical course, with the patient surviving for more
than 48 months without any sign of recurrence. This case
was presented with gastrointestinal bleeding, which con-
tributed to early diagnosis, whereas the other previous
cases in literature presented either with abdominal pain or
jaundice. Hence, the good prognosis in present case could
also be due to its earlier presentation. The lesion in the
present case showed a different immunohistological char-
acter from that in other cases, such as no immunoreactiv-
ity to neuron-specific enolase (NSE) or chromogranin A.
Table 1: Immunochemical characteristics of the two components of the tumor.
Synaptophysi
n
AE1/AE3 Vimentin CD56 chromograni
n A
MIB1
(A) Round 
component
++ ++ ++ + - 25%
(B) Crescent 
component
+ - - - - 50%
LCA, L26, UCHL1, CD3, ASMA, M-actin, desmin, CD34, NF, GFAP, and S100 were negative in both components.
Table 2: Profiles of the cases of primary small-cell neuroendocrine carcinoma in the duodenum reported in the literature.
Author 
Year
Age/
sex
Clinical 
Manifestations
Size 
(mm)
Morphology Location Metastasis Surgery Chemotherapy Prognosis
(month)
1S w a n s o n  
1986 [7]
76 M Abdominal pain, 
anorexia, weight 
loss
15 ulceration adjacent 
to the 
ampulla*
LN, liver biospy 5-FU,
doxorubicin,
mitomycin
Dead (1.5)
2 Zamboni 
1990 [8]
62 M jaundice, weight 
loss
25 polypoid the papilla 
of Vater
LN PD - Dead (7)
3 Zamboni 
1990 [8]
66 M jaundice, 
abdominal pain
20 ulceration the papilla 
of Vater
LN PD - Dead (6)
4 Zamboni 
1990 [8]
51 M jaundice, weight 
loss, abdominal 
pain
30 soft fungating 
mass
the papilla 
of Vater
LN PD - Dead (17)
5 Lee 1992 
[9]
86 M jaundice, 
recurrent 
pancreatitis
? polypoid Peri 
ampullary
?- - ( > 5 )
6S a r k e r  
1992 
[10]
53 F jaundice, weight 
loss, back pain
35 mass with 
small 
ulceration
the papilla 
of Vater
LN PD 5-FU, TNF,
interferon
Recurrence +
(>18)
7S a t o  
1995 
[11]
74 M jaundice 35 polypoid the papilla 
of Vater
? PPPD - ?
8S h i m  
2000 
[12]
54 M jaundice 30 ulceration the papilla 
of Vater
liver PD cisplatin,
etoposide,
radiation
Dead (8)
9S a t a  
2004 
present 
case
57 M GI Tract 
bleeding
30 mass with 
ulceration
Peri 
ampullary
-L o c a l
resection
5-FU leucovorin disease free
(>48)
* Hormone VIP; ? Don't know; M – male; F – Female; PD-pancreaticoduodenectomy; LN-lymph node; PPPD-pylorus preserving 
pancreaticoduodenectomy; 5 FU-f fluoro uracil; TNF – tumor necrosis factorWorld Journal of Surgical Oncology 2004, 2:28 http://www.wjso.com/content/2/1/28
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These differences too might partly explain the different
character of this case.
Conclusions
This report identifies a new subtype of small-cell NEC in
the duodenum. This subtype appears to have a much bet-
ter prognosis, and may be amenable to local excision, if
the lesion is away from the ampulla of Vater.
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Immunostaining for AE1/AE3 showing (a) diffuse cytoplasmic positivity in the component A, and (b) no reactivity in the compo- nent B Figure 3
Immunostaining for AE1/AE3 showing (a) diffuse cytoplasmic positivity in the component A, and (b) no reactivity in the compo-
nent B.World Journal of Surgical Oncology 2004, 2:28 http://www.wjso.com/content/2/1/28
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Ultrastructural study showed cytoplasmic dense-core granules in the component A Figure 4
Ultrastructural study showed cytoplasmic dense-core granules in the component A.Publish with BioMed Central    and   every 
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